Company Profile
Established in year 2003, diversified into API manufacturing in 2003 and consolidated position in domestic market for the API Business. Leading Niche specialty player in domestic formulation business from year 2006. Expanded to have two API facilities at Gujarat and 2 formulation facilities at Gujarat and Uttarakhand. .
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Adapalene |
2-Naphthalenecarboxylic acid,6-(4-methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-;6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid;CD 271;Adapalene;Differin;6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthalenecarboxylic acid;Differin Gel;6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid;CD 271 (pharmaceutical);Aclene Gel;Aclene;6-(3-(Adamantan-1-yl)-4-methoxyphenyl)-2-naphthoic acid |
106685-40-9 | Inquiry | |
Diacerein |
2-Anthracenecarboxylic acid,4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-;2-Anthroic acid,9,10-dihydro-4,5-dihydroxy-9,10-dioxo-,diacetate;Rhein,diacetate;4,5-Bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid;1,8-Diacetoxy-3-carboxyanthraquinone;Diacetylrhein;4,5-Diacetylrhein;Diacerhein;Diacerein;4,5-Diacetoxyanthraquinone-2-carboxylic acid;DAR;SF 277;Fisiodar;Artrodar;4,5-Diacetoxy-9,10-dioxoanthracene-2-carboxylic acid;Osteocerein;AC 201;Inflabion |
13739-02-1 | Inquiry | |
Etoricoxib |
2,3′-Bipyridine,5-chloro-6′-methyl-3-[4-(methylsulfonyl)phenyl]-;5-Chloro-6′-methyl-3-[4-(methylsulfonyl)phenyl]-2,3′-bipyridine;Etoricoxib;MK 663;MK 0663;Arcoxia;Torcoxia;Kingcox;Etocox;Etobrix;Etoxib;Etropain;Algix;Tauxib;Nucoxia;Etosaid |
202409-33-4 | Inquiry | |
Gemifioxacin |
1,8-Naphthyridine-3-carboxylic acid,7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-;7-[(4Z)-3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid;LB 20304;Gemifloxacin;SB 265805;204519-64-2;210353-52-9;214346-11-9 |
175463-14-6 | Inquiry | |
Irbesartan |
1,3-Diazaspiro[4.4]non-1-en-4-one,2-butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;1,3-Diazaspiro[4.4]non-1-en-4-one,2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;2-Butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;SR 47436;2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one;Irbesartan;BMS 186295;Avapro;Aprovel;Karvea;2-Butyl-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]-methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;Irbetan;Irbest;Kansartan;X-Tension;3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one;2-Butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;2-Butyl-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one;Sabervel;200762-06-7 |
138402-11-6 | Inquiry | |
Levetiracetam |
1-Pyrrolidineacetamide,α-ethyl-2-oxo-,(αS)-;1-Pyrrolidineacetamide,α-ethyl-2-oxo-,(S)-;(αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide;UCB-L 059;Levetiracetam;Keppra;Levesam 500;(-)-Levetiracetam;Levroxa;(-)-(S)-α-Ethyl-2-oxo-1-pyrrolidineacetamide;Levipil;(S)-Levetiracetam;Levesam;Spritam;(S)-2-(2-Oxopyrrolidin-1-yl)butanamide;(2S)-2-(2-Oxopyrrolidin-1-yl)butanamide;AGB 101 (low-dose levetiracetam);AGB 101;Varuby;Matever |
102767-28-2 | Inquiry | |
Lornoxicam |
2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide,6-chloro-4-hydroxy-2-methyl-N-2-pyridinyl-,1,1-dioxide;Lornoxicam;Chlortenoxicam;Ro 13-9297;TS 110;Telos;Xefo;Xefocam;Lorcam;Lofecam;Fulactive |
70374-39-9 | Inquiry | |
Moxifloxacin hydrochloride |
3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-,hydrochloride (1:1);3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-,monohydrochloride,(4aS-cis)-;3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-,monohydrochloride;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1);Moxifloxacin hydrochloride;BAY 12-8039;Avalox;Avelox;Octegra;Lapinix;Actira;Avelonm |
186826-86-8 | Inquiry | |
Olmesartan |
1H-Imidazole-5-carboxylic acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;1H-Imidazole-5-carboxylic acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid;RNH 6270;Olmesartan;CS 088;Olmetor |
144689-24-7 | Inquiry | |
Ranolazine |
1-Piperazineacetamide,N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-;1-Piperazineacetamide,N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-,(±)-;N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide;(±)-Ranolazine;Ranolazine;CVT 303;Ranexa;RS 43285-003;Renexa;4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethyl)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one;142387-99-3 |
95635-55-5 | Inquiry | |
Telmisartan |
[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-;4′-[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid;BIBR 277;Telmisartan;4′-[[4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid;BIBR 277SE;Micardis;Pritor;Telday;Kinzalmono;Telsar;Telsite;Telmisartar;2-[4-[[4-Methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid;2-(4-[[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl]phenyl)benzoic acid;Tolura;Semintra |
144701-48-4 | Inquiry | |
Torasemide |
3-Pyridinesulfonamide,N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-;N-[[(1-Methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide;Torasemide;AC 4464;BM 02015;Torsemide;Luprac;Demadex;Torem;Toradiur;Unat;JDL 464;BM 02.015;Dilutol;Tide 10;Examide;1-([4-[(3-Methylphenyl)amino]pyridin-3-yl]sulfonyl)-3-(propan-2-yl)urea;1-[4-(3-Methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea;UpCard;Isemid |
56211-40-6 | Inquiry | |
Voglibose |
D-epi-Inositol,3,4-dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-;3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epi-inositol;N-(1,3-Dihydroxy-2-propyl)valiolamine;Voglibose;AO 128;Glustat;A 71100;Basen;Voglistat;(1S,2S,3R,4S,5S)-5-[(1,3-Dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol;(1S,2S,3R,4S,5S)-5-((1,3-Dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol;112653-29-9 |
83480-29-9 | Inquiry | |
Zidovudine |
Thymidine,3′-azido-3′-deoxy-;3′-Azido-3′-deoxythymidine;Azidothymidine;3′-Deoxy-3′-azidothymidine;AZT;BW-A 509U;AZT (pharmaceutical);Zidovudine;Retrovir;3′-Azidothymidine;NSC 602670;Azitidin;ZDV;Timazid;Retrovir IV;ZVD;3-Azido-3-deoxythymidine;Compound S;Viro-Z;Zido-H;Retrovis;3′-AZT;399024-19-2;1350915-89-7;1904592-23-9;2471391-52-1 |
30516-87-1 | Inquiry |